Arthritis Research & Therapy

official impact factor 4.36

Open Access

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis

Gilles Boire*, Pierre Cossette, Artur J de Brum-Fernandes, Patrick Liang, Théophile Niyonsenga, Zhijie J Zhou, Nathalie Carrier, Claude Daniel and Henri-A Ménard

Arthritis Research & Therapy 2005, 7:R592-R603 doi:10.1186/ar1719

Accesses  

  • Last 30 days: 68 accesses
  • Last year: 710 accesses
  • All time: 6209 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA

Parawee Suwannalai, Annemiek Willemze, Linda van Toorn, Gerrie Stoeken-Rijsbergen, Nivine Levarht, Jan Drijfhout, Tom W J Huizinga, Rene E M Toes, Leendert A Trouw Arthritis Research & Therapy 2011, 13:R195 (30 November 2011)

Research article   Open Access Highly Accessed

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis

Olivier Meyer, Pascale Nicaise-Roland, Marie Santos, Colette Labarre, Maxime Dougados, Philippe Goupille, Alain Cantagrel, Jean Sibilia, Bernard Combe Arthritis Research & Therapy 2006, 8:R40 (26 January 2006)